🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, observational, multicenter, cohort study with 400 ne...
Status
Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Start Date
2025-01-01
Trial ID
NCT06779435
Treatments Being Tested
A randomized phase III multicenter trial assessing efficacy and toxicity of...
Status
Active Not Recruiting
Location
ASST Grande Ospedale Metropolitano Niguarda
Start Date
2014-05
Trial ID
NCT02390869
An open-label, non-randomized, phase II study to assess the safety and effi...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2020-08-31
Trial ID
NCT04548440
Treatments Being Tested
The goal of this clinical trial is to learn whether repeated cisplatin-base...
Status
Recruiting
Location
Moscow Regional Oncological Dispensary
Start Date
2025-04-02
Trial ID
NCT07514494
Treatments Being Tested
In this study，lenalidomide was added in the first-line treatment in the new...
Status
Unknown
Location
Department of Hematology, Provincial Hospital Affiliated to Shandong University
Start Date
2019-06-05
Trial ID
NCT04152577
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as epirubicin, oxaliplatin, flu...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2008-01-05
Trial ID
NCT00601705
Treatments Being Tested
Background: Primary effusion lymphoma (PEL) is a rare disease with no stan...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2017-07-03
Trial ID
NCT02911142
The trial is an open-label, multi-center safety and preliminary efficacy tr...
Status
Active Not Recruiting
Location
Tohoku University Hoaspital
Start Date
2020-08-20
Trial ID
NCT04542824
A Randomized Multicenter Phase III Study to Evaluate the Role of All-trans ...
Status
Withdrawn
Location
Chu Amiens Sud
Start Date
2010-04
Trial ID
NCT01067274
Treatments Being Tested
Asparaginase is a cornerstone in the treatment of ALL, but its utility is l...
Status
Completed
Location
Hopital Des Enfants Reine Fabiola
Start Date
2009-12
Trial ID
NCT01518517
Treatments Being Tested